標(biāo)題: Titlebook: Applications of FDG PET in Oncology; Best Clinical Practi Hirofumi Fujii,Hiroyuki Nakamura,Seiei Yasuda Book 2021 Springer Nature Singapore [打印本頁] 作者: 淺吟低唱 時間: 2025-3-21 17:00
書目名稱Applications of FDG PET in Oncology影響因子(影響力)
書目名稱Applications of FDG PET in Oncology影響因子(影響力)學(xué)科排名
書目名稱Applications of FDG PET in Oncology網(wǎng)絡(luò)公開度
書目名稱Applications of FDG PET in Oncology網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Applications of FDG PET in Oncology被引頻次
書目名稱Applications of FDG PET in Oncology被引頻次學(xué)科排名
書目名稱Applications of FDG PET in Oncology年度引用
書目名稱Applications of FDG PET in Oncology年度引用學(xué)科排名
書目名稱Applications of FDG PET in Oncology讀者反饋
書目名稱Applications of FDG PET in Oncology讀者反饋學(xué)科排名
作者: Tonometry 時間: 2025-3-21 21:04
The Role of 18F-FDG-PET as Therapeutic Monitoring in Patients with Lung Cancer,lationship between .F-FDG uptake and PD-L1 expression has also been investigated in different kinds of institutions, with similar results..F-FDG-PET is a useful modality for cancer diagnosis, with an expanding role to therapeutic monitoring of cancer chemotherapy.作者: 摻和 時間: 2025-3-22 03:41
F-18 FDG PET Tests in Breast Cancer,ecially high in triple-negative breast cancer and younger patients..FDG PET is also used to evaluate the tumor response after neoadjuvant chemotherapy (NAC) and predict the final response at early cycles of NAC. In several clinical trials, FDG PET is used for the early evaluation of NAC for response作者: lipids 時間: 2025-3-22 07:43
F-18 FDG PET Tests in Head and Neck Cancer,sponse to radiotherapy; and prediction of the treatment response and survival..Several studies have discussed the utility of FDG PET/CT. This chapter briefly summarizes the utility of FDG PET/CT for the management of HNSCC and the limitations associated with its clinical use.作者: Bravura 時間: 2025-3-22 11:13 作者: agitate 時間: 2025-3-22 15:12 作者: 清唱劇 時間: 2025-3-22 19:35 作者: 哪有黃油 時間: 2025-3-23 01:06
Encyclopedia of Metalloproteinsecially high in triple-negative breast cancer and younger patients..FDG PET is also used to evaluate the tumor response after neoadjuvant chemotherapy (NAC) and predict the final response at early cycles of NAC. In several clinical trials, FDG PET is used for the early evaluation of NAC for response作者: 可忽略 時間: 2025-3-23 04:47
A Kinase Anchoring Protein 150 (AKAP150)sponse to radiotherapy; and prediction of the treatment response and survival..Several studies have discussed the utility of FDG PET/CT. This chapter briefly summarizes the utility of FDG PET/CT for the management of HNSCC and the limitations associated with its clinical use.作者: 翻布尋找 時間: 2025-3-23 06:02
where the universal public health insurance system ensures that FDG PET is widely used in routine oncological practice and cancer screening. It represents an unrivaled and comprehensive resource that will be of value for all healthcare professionals in the field of clinical oncology..978-981-15-8425-1978-981-15-8423-7作者: Trigger-Point 時間: 2025-3-23 13:39
Chih-Chang Chang,Lung-Ming Fu,Ruey-Jen Yangreatment of melanoma and some skin cancers, possibility of using .F-FDG PET-CT to monitor response and predict long-term outcome is under investigation. However, we should be aware of the fact that .F-FDG uptake is not specific for malignant neoplasms since inflammation, infection, or a benign tumor can show focal .F-FDG uptake.作者: 話 時間: 2025-3-23 14:24 作者: 整理 時間: 2025-3-23 19:40 作者: defenses 時間: 2025-3-23 22:55
F-18 FDG PET Tests in Malignant Lymphoma,esponse assessment. Although its usefulness remains under investigation, interim PET is expected to become a useful biomarker for the prediction of treatment outcome and the stratification of treatment.作者: 古代 時間: 2025-3-24 04:02
Book 2021, including, for example, lung cancer, breast cancer, head and neck cancer, gastrointestinal cancer, and malignant lymphoma. In the era of precision medicine, numerous new anticancer agents, such as molecular targeted agents and immune checkpoint inhibitors, have been developed to improve outcomes i作者: 過于平凡 時間: 2025-3-24 08:11 作者: integrated 時間: 2025-3-24 11:11 作者: canonical 時間: 2025-3-24 18:12 作者: 凝視 時間: 2025-3-24 22:13 作者: NICE 時間: 2025-3-25 02:40
Actinides, Interactions with Proteinscused only on therapeutic monitoring. This study reviewed and discussed the role of therapeutic monitoring of molecular target agents, angiogenetic inhibitors, and immune checkpoint inhibitors (ICIs) in patients with lung cancer. ICIs including anti-programmed death-1 (PD-1)/programmed death-ligand 作者: Formidable 時間: 2025-3-25 03:22 作者: Microgram 時間: 2025-3-25 09:12 作者: 有毛就脫毛 時間: 2025-3-25 12:54
Encyclopedia of Metalloproteinsdalities. In the diagnosis of the degree of the primary lesion by PET/CT, it is possible to diagnose the presence by the size and the degree of FDG accumulation. In the diagnostic ability of lateral pelvic lymph node metastasis, local recurrence and peritonitis carcinomatosa, qualitative diagnosis b作者: BOLUS 時間: 2025-3-25 16:10
Actinides, Physical and Chemical Propertiess urological cancer, including renal cell carcinoma, testicular cancer, and bladder cancer, by FDG PET/CT utilizing this characteristic were reported. These studies encouraged that FDG PET/CT had a potency to provide critical information when the treatment strategy was decided under various situatio作者: Limpid 時間: 2025-3-25 21:47
Chih-Chang Chang,Lung-Ming Fu,Ruey-Jen Yangermediate tumor tissues as well. PET/MRI or PET/CT scanning is performed to diagnose malignancies, detect a location for biopsy, evaluate the effect of chemotherapy, and identify metastases and local recurrences. But evaluating tumor invasion for surgical planning is crucial and can be difficult or 作者: 易于 時間: 2025-3-26 00:26
Chih-Chang Chang,Lung-Ming Fu,Ruey-Jen Yangignancies including both carcinoma and sarcoma. .F-FDG PET-CT scan is considered as the most sensitive and accurate diagnostic tool for patients with >pT3a malignant melanoma and Merkel cell carcinoma. However, .F-FDG PET-CT has not been validated to assess the response to therapy in any type of ski作者: 策略 時間: 2025-3-26 07:54 作者: Eclampsia 時間: 2025-3-26 11:47 作者: Entreaty 時間: 2025-3-26 16:01 作者: 挑剔小責(zé) 時間: 2025-3-26 19:52 作者: 不能平靜 時間: 2025-3-27 00:52 作者: patriot 時間: 2025-3-27 02:50 作者: 圣歌 時間: 2025-3-27 05:39 作者: 窗簾等 時間: 2025-3-27 10:25 作者: 歹徒 時間: 2025-3-27 15:09
Bone and Soft-Tissue Tumors,ermediate tumor tissues as well. PET/MRI or PET/CT scanning is performed to diagnose malignancies, detect a location for biopsy, evaluate the effect of chemotherapy, and identify metastases and local recurrences. But evaluating tumor invasion for surgical planning is crucial and can be difficult or even impossible, even if PET/MRI is performed.作者: indecipherable 時間: 2025-3-27 19:03 作者: paroxysm 時間: 2025-3-27 22:39 作者: 使饑餓 時間: 2025-3-28 02:07 作者: 后退 時間: 2025-3-28 06:15 作者: 不合 時間: 2025-3-28 11:47 作者: 跑過 時間: 2025-3-28 18:13 作者: Fantasy 時間: 2025-3-28 21:36 作者: 滲入 時間: 2025-3-29 01:44 作者: 匍匐前進(jìn) 時間: 2025-3-29 06:37
F-18 FDG PET Tests in Malignant Lymphoma,can. Moreover, since publication of the Lugano classification in 2014, .F-fluorodeoxyglucose (FDG) PET/CT is now commonly used for evaluating lymphoma lesions, staging, and response assessment in patients with lymphoma. With the exception for some indolent lymphoma, almost all subtypes are FDG-avid.作者: CODE 時間: 2025-3-29 09:00
9樓作者: Ondines-curse 時間: 2025-3-29 13:33
9樓作者: 否決 時間: 2025-3-29 19:20
10樓作者: 吞沒 時間: 2025-3-29 21:18
10樓作者: Notify 時間: 2025-3-30 03:39
10樓作者: 喊叫 時間: 2025-3-30 05:59
10樓
